GLEPAGLUTIDE, A NOVEL LONG-ACTING GLP-2 ANALOGUE, EXPOSURE DOES NOT CORRELATE WITH HEPATIC INDOCYANINE GREEN CLEARANCE

Mikkel Askjær Agersnap  1     Kim Sonne  1     Birgitte Biilmann Rønn  1     Mark Berner-Hansen  1     Rahim Naimi  2     Mark Krogh Hvistendahl  2     Rikard Ambrus  2     Nikolaj Albeck Nerup  2     Lars Bo Svendsen  2     Palle Bekker Jeppesen  2    
1 Zealand Pharma A/S, Søborg, Denmark
2 Rigshospitalet, Copenhagen, Denmark

Conference
UEG Week Virtual 2021

Citation
United European Gastroenterology Journal 2021; 9 (Supplement 8)


Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Social Sharing